Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,128 | 572 | 99.9% |
| Education | $11.65 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,538 | 109 | $0 (2024) |
| Amgen Inc. | $735.07 | 42 | $0 (2024) |
| PFIZER INC. | $647.87 | 49 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $553.78 | 39 | $0 (2024) |
| ABBVIE INC. | $428.32 | 31 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $424.64 | 24 | $0 (2024) |
| GlaxoSmithKline, LLC. | $398.62 | 28 | $0 (2024) |
| Lilly USA, LLC | $390.20 | 30 | $0 (2024) |
| Merck Sharp & Dohme LLC | $365.23 | 39 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $283.89 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,440 | 83 | Novo Nordisk Inc ($316.08) |
| 2023 | $1,202 | 71 | Novo Nordisk Inc ($254.75) |
| 2022 | $976.69 | 60 | Novo Nordisk Inc ($227.90) |
| 2021 | $957.53 | 68 | Boehringer Ingelheim Pharmaceuticals, Inc. ($144.49) |
| 2020 | $663.38 | 45 | Novo Nordisk Inc ($76.28) |
| 2019 | $1,177 | 106 | Novo Nordisk Inc ($210.55) |
| 2018 | $832.20 | 62 | Amgen Inc. ($149.24) |
| 2017 | $891.39 | 79 | Novo Nordisk Inc ($191.10) |
All Payment Transactions
574 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $4.25 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: Diabetes Care | ||||||
| 11/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: PAIN | ||||||
| 11/19/2024 | Seqirus USA Inc | Fluad (Biological), Flucelvax | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Vaccines | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Diabetes | ||||||
| 11/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: VACCINES | ||||||
| 10/31/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $7.43 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: DIABETES | ||||||
| 10/24/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $28.54 | General |
| Category: Diabetes | ||||||
| 10/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: Obesity | ||||||
| 10/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Oncology | ||||||
| 10/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: PAIN | ||||||
| 10/03/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Diabetes Care | ||||||
| 09/24/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Hepatitis B Vaccine | ||||||
| 09/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Inflammation | ||||||
| 09/12/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $28.14 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 08/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Obesity | ||||||
| 08/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $8.08 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 1,724 | 2,440 | $200,168 | $75,582 |
| 2022 | 31 | 1,714 | 2,456 | $187,404 | $71,633 |
| 2021 | 32 | 1,859 | 2,701 | $190,093 | $80,515 |
| 2020 | 28 | 1,617 | 2,373 | $156,482 | $59,224 |
All Medicare Procedures & Services
124 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 147 | 271 | $62,330 | $19,524 | 31.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 114 | 114 | $37,620 | $13,041 | 34.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 93 | 145 | $22,910 | $7,377 | 32.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 22 | 22 | $10,494 | $5,643 | 53.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 57 | 57 | $4,845 | $3,949 | 81.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 158 | 329 | $4,376 | $2,655 | 60.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 154 | 261 | $5,481 | $2,642 | 48.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 124 | 187 | $5,984 | $2,392 | 40.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 82 | 82 | $3,854 | $2,304 | 59.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 20 | $6,180 | $2,007 | 32.5% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 14 | 14 | $5,866 | $2,002 | 34.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 108 | 108 | $5,400 | $1,741 | 32.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 112 | 183 | $4,209 | $1,696 | 40.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 21 | 21 | $1,554 | $1,523 | 98.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 51 | 74 | $2,960 | $1,187 | 40.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 75 | 109 | $2,071 | $821.88 | 39.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 21 | 21 | $987.00 | $568.80 | 57.6% |
| 82306 | Vitamin d-3 level | Office | 2023 | 19 | 19 | $1,311 | $551.19 | 42.0% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 14 | 14 | $1,610 | $531.02 | 33.0% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 24 | 24 | $1,032 | $454.08 | 44.0% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 35 | 51 | $1,071 | $442.00 | 41.3% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 13 | 29 | $783.00 | $405.50 | 51.8% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 58 | 63 | $2,016 | $339.60 | 16.8% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 12 | 16 | $1,312 | $317.20 | 24.2% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 59 | 64 | $832.00 | $309.88 | 37.2% |
About Dr. Brad Flaming, MD
Dr. Brad Flaming, MD is a Family Medicine healthcare provider based in Powell, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265474936.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brad Flaming, MD has received a total of $8,139 in payments from pharmaceutical and medical device companies, with $1,440 received in 2024. These payments were reported across 574 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($8,128).
As a Medicare-enrolled provider, Flaming has provided services to 6,914 Medicare beneficiaries, totaling 9,970 services with total Medicare billing of $286,953. Data is available for 4 years (2020–2023), covering 124 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Powell, TN
- Active Since 06/10/2006
- Last Updated 04/28/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1265474936
Products in Payments
- JARDIANCE (Drug) $533.59
- Ozempic (Drug) $525.56
- Rybelsus (Drug) $317.73
- VRAYLAR (Drug) $281.68
- NURTEC ODT (Drug) $263.16
- JANUVIA (Drug) $261.45
- Otezla (Drug) $247.16
- Victoza (Drug) $228.42
- Vascepa (Drug) $203.88
- Prolia (Biological) $198.66
- REXULTI (Drug) $175.60
- Kerendia (Drug) $165.08
- Aimovig (Biological) $160.70
- FARXIGA (Drug) $159.58
- Saxenda (Drug) $159.19
- ELIQUIS (Drug) $155.33
- XARELTO (Drug) $147.67
- CHANTIX (Drug) $144.45
- BEXSERO (Biological) $143.66
- SHINGRIX (Biological) $141.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Powell
Mark Johnson, Md, MD
Family Medicine — Payments: $14,291
Kathy Chism, Md, MD
Family Medicine — Payments: $8,090
Nicholas Thornton, Md, MD
Family Medicine — Payments: $7,874
Rhea Dean, Md, MD
Family Medicine — Payments: $5,491
Julius Vonclef, Md, MD
Family Medicine — Payments: $4,741
Lee Toney, Md, MD
Family Medicine — Payments: $4,516